C. Tsui

Next-generation sequencing with a myeloid gene panel in core-binding factor AML showed KIT activation loop and TET2 mutations predictive of outcome

E. Ma, T. Chan, Y. Kwong, 2016, Blood Cancer Journal.

Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy.

T. Graeber, A. Ribas, Stephen Mok, 2014, Cancer research.

Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy.

T. Graeber, A. Ribas, Stephen Mok, 2014, Cancer research.